Kangdong Liu

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 29

Top Topics

Top Venues

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Yunshu Shi, Junyong Wang, Qiang Yuan, Yingying Chen, Miao Zhao, Xiaoyu Li, Zitong Wang, Hao Zhou, Fangli Zhu, Bing Wei, Yanan Jiang, Jimin Zhao, Yan Qiao, Zigang Dong, Kangdong Liu
DDX5 promotes esophageal squamous cell carcinoma growth through sustaining VAV3 mRNA stability. Oncogene (2024)
Liting Zhou, Jie Tian, Keke Wang, Yijie Ma, Xiaojie Chen, Hui Luo, Bingbing Lu, Nan Wang, Penglei Wang, Xuejiao Liu, Ran Zhao, Simin Zhao, Jiutao Wang, Wenna Nie, Hong Ge, Wenting Liu, Tingxuan Gu, Kangdong Liu, Mee-Hyun Lee, Xiang Li, Zigang Dong
Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma. Cancer research (2024)
Yamei Hu, Zigang Dong, Kangdong Liu
Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Yamei Hu, Zigang Dong, Kangdong Liu
Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Xinning Liu, Yanan Jiang, Hao Zhou, Xiaokun Zhao, Mingzhu Li, Zhuo Bao, Zitong Wang, Chenyang Zhang, Zhenliang Xie, Jimin Zhao, Zigang Dong, Kangdong Liu, Zhiping Guo
Dasabuvir suppresses esophageal squamous cell carcinoma growth in vitro and in vivo through targeting ROCK1. Cell death & disease 14 (2) (2023)
Mingzhu Li, Lina Duan, Wenjie Wu, Wenjing Li, Lili Zhao, Ang Li, Xuebo Lu, Xinyu He, Zigang Dong, Kangdong Liu, Yanan Jiang
Vortioxetine hydrobromide inhibits the growth of gastric cancer cells in vivo and in vitro by targeting JAK2 and SRC. Oncogenesis 12 (1) (2023)
Qiang Yuan, Yi Chu, Xiaoyu Li, Yunshu Shi, Yingying Chen, Jimin Zhao, Jing Lu, Kangdong Liu, Yaping Guo
CAFrgDB: a database for cancer-associated fibroblasts related genes and their functions in cancer. Cancer gene therapy (2023)
Simin Zhao, Jian Li, Qingxin Xia, Kangdong Liu, Zigang Dong
New perspectives for targeting therapy in ALK-positive human cancers. Oncogene (2023)
Xinning Liu, Yanan Jiang, Hao Zhou, Xiaokun Zhao, Mingzhu Li, Zhuo Bao, Zitong Wang, Chenyang Zhang, Zhenliang Xie, Jimin Zhao, Zigang Dong, Kangdong Liu, Zhiping Guo
Dasabuvir suppresses esophageal squamous cell carcinoma growth in vitro and in vivo through targeting ROCK1. Cell death & disease 14 (2) (2023)
Wenjie Wu, Jialuo Xu, Dan Gao, Zhenliang Xie, Wenjing Chen, Wenjing Li, Qiang Yuan, Lina Duan, Yuhan Zhang, Xiaoxiao Yang, Yingying Chen, Ziming Dong, Kangdong Liu, Yanan Jiang
TOPK promotes the growth of esophageal cancer in vitro and in vivo by enhancing YB1/eEF1A1 signal pathway. Cell death & disease 14 (6) (2023)
Mingzhu Li, Lina Duan, Wenjie Wu, Wenjing Li, Lili Zhao, Ang Li, Xuebo Lu, Xinyu He, Zigang Dong, Kangdong Liu, Yanan Jiang
Vortioxetine hydrobromide inhibits the growth of gastric cancer cells in vivo and in vitro by targeting JAK2 and SRC. Oncogenesis 12 (1) (2023)
Xinning Liu, Yanan Jiang, Hao Zhou, Xiaokun Zhao, Mingzhu Li, Zhuo Bao, Zitong Wang, Chenyang Zhang, Zhenliang Xie, Jimin Zhao, Zigang Dong, Kangdong Liu, Zhiping Guo
Dasabuvir suppresses esophageal squamous cell carcinoma growth in vitro and in vivo through targeting ROCK1. Cell death & disease 14 (2) (2023)
Mingzhu Li, Lina Duan, Wenjie Wu, Wenjing Li, Lili Zhao, Ang Li, Xuebo Lu, Xinyu He, Zigang Dong, Kangdong Liu, Yanan Jiang
Vortioxetine hydrobromide inhibits the growth of gastric cancer cells in vivo and in vitro by targeting JAK2 and SRC. Oncogenesis 12 (1) (2023)
Mingzhu Li, Lina Duan, Wenjie Wu, Wenjing Li, Lili Zhao, Ang Li, Xuebo Lu, Xinyu He, Zigang Dong, Kangdong Liu, Yanan Jiang
Vortioxetine hydrobromide inhibits the growth of gastric cancer cells in vivo and in vitro by targeting JAK2 and SRC. Oncogenesis 12 (1) (2023)
Xinyu He, Yubing Zhou, Wenjing Chen, Xiaokun Zhao, Lina Duan, Hao Zhou, Mingzhu Li, Yin Yu, Jimin Zhao, Yaping Guo, Huihui Gu, Yanan Jiang, Zigang Dong, Kangdong Liu
Repurposed pizotifen malate targeting NRF2 exhibits anti-tumor activity through inducing ferroptosis in esophageal squamous cell carcinoma. Oncogene (2023)
Yihuan Chen, Xiaoshuo Dai, Wei Chen, Yan Qiao, Ruihua Bai, Xiaoxuan Duan, Kai Zhang, Xinhuan Chen, Xin Li, Saijun Mo, Wenbo Cao, Xiang Li, Kangdong Liu, Ziming Dong, Jing Lu
Diosmetin suppresses the progression of ESCC by CDK2/Rb/E2F2/RRM2 pathway and synergies with cisplatin. Oncogene (2023)
Wei Chen, Qiushuang Zhang, Xiaoshuo Dai, Xinhuan Chen, Chengjuan Zhang, Ruihua Bai, Yihuan Chen, Kai Zhang, Xiaoxuan Duan, Yan Qiao, Jimin Zhao, Fang Tian, Kangdong Liu, Ziming Dong, Jing Lu
PGC-1α promotes colorectal carcinoma metastasis through regulating ABCA1 transcription. Oncogene (2023)
Zitong Wang, Yingying Chen, Xiaoyu Li, Yuhan Zhang, Xiaokun Zhao, Hao Zhou, Xuebo Lu, Lili Zhao, Qiang Yuan, Yunshu Shi, Jimin Zhao, Ziming Dong, Yanan Jiang, Kangdong Liu
Tegaserod Maleate Suppresses the Growth of Gastric Cancer In Vivo and In Vitro by Targeting MEK1/2. Cancers 14 (15) (2022)
Ning Yang, Xuebo Lu, Yanan Jiang, Lili Zhao, Donghao Wang, Yaxing Wei, Yin Yu, Myoung Ok Kim, Kyle Vaughn Laster, Xin Li, Baoyin Yuan, Zigang Dong, Kangdong Liu
Arbidol inhibits human esophageal squamous cell carcinoma growth in vitro and in vivo through suppressing ataxia telangiectasia and Rad3-related protein kinase. eLife 11 (2022)
Zhuo Bao, Ang Li, Xuebo Lu, Zitong Wang, Yin Yu, Wenjie Wu, Lili Zhao, Bo Li, Xiangyu Wu, Kyle Vaughn Laster, Chengjuan Zhang, Yanan Jiang, Zigang Dong, Kangdong Liu
Oxethazaine inhibits esophageal squamous cell carcinoma proliferation and metastasis by targeting aurora kinase A. Cell death & disease 13 (2) (2022)
Haibo Zhang, Jun-Koo Yi, Hai Huang, Song Park, Sijun Park, Wookbong Kwon, Eungyung Kim, Soyoung Jang, Si-Yong Kim, Seong-Kyoon Choi, Sung-Hyun Kim, Kangdong Liu, Zigang Dong, Zae Young Ryoo, Myoung Ok Kim
Rhein Suppresses Colorectal Cancer Cell Growth by Inhibiting the mTOR Pathway In Vitro and In Vivo. Cancers 13 (9) (2021)
Chuntian Huang, Ruijuan Du, Xuechao Jia, Kangdong Liu, Yan Qiao, Qiong Wu, Ning Yao, Lu Yang, Liting Zhou, Xuejiao Liu, Pu Xiang, Mingxia Xin, Yan Wang, Xiaojie Chen, Dong Joon Kim, Zigang Dong, Xiang Li
CDK15 promotes colorectal cancer progression via phosphorylating PAK4 and regulating β-catenin/ MEK-ERK signaling pathway. Cell death and differentiation (2021)
Qiong Wu, Fangfang Liu, Mengmeng Ge, Kyle Vaughn Laster, Lixiao Wei, Ruijuan Du, Ming Jiang, Jing Zhang, Yafei Zhi, Guoguo Jin, Simin Zhao, Dong Joon Kim, Zigang Dong, Kangdong Liu
BRD4 drives esophageal squamous cell carcinoma growth by promoting RCC2 expression. Oncogene (2021)
Yamei Hu, Fangfang Liu, Xuechao Jia, Penglei Wang, Tingxuan Gu, Hui Liu, Tingting Liu, Huifang Wei, Hanyong Chen, Jiuzhou Zhao, Ran Yang, Yingying Chen, Zigang Dong, Kangdong Liu
Periplogenin suppresses the growth of esophageal squamous cell carcinoma in vitro and in vivo by targeting STAT3. Oncogene 40 (23) (2021)
Hai Huang, Jun-Koo Yi, Su-Geun Lim, Sijun Park, Haibo Zhang, Eungyung Kim, Soyoung Jang, Mee-Hyun Lee, Kangdong Liu, Ki-Rim Kim, Eun-Kyong Kim, Youngkyun Lee, Sung-Hyun Kim, Zae-Young Ryoo, Myoung Ok Kim
Costunolide Induces Apoptosis via the Reactive Oxygen Species and Protein Kinase B Pathway in Oral Cancer Cells. International journal of molecular sciences 22 (14) (2021)
Yaxing Wei, Wenjie Wu, Yanan Jiang, Hao Zhou, Yin Yu, Lili Zhao, Xiangyu Wu, Xuebo Lu, Qiang Yuan, Zitong Wang, Zigang Dong, Luyun He, Jimin Zhao, Kangdong Liu
Nuplazid suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting PAK4. British journal of cancer 126 (7) (2021)
Hai Huang, Mee-Hyun Lee, Kangdong Liu, Zigang Dong, Zeayoung Ryoo, Myoung Ok Kim
PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential. Cancers 13 (9) (2021)
Ah-Won Kwak, Joon-Seok Choi, Kangdong Liu, Mee-Hyun Lee, Young-Joo Jeon, Seung-Sik Cho, Goo Yoon, Ha-Na Oh, Jung-Il Chae, Jung-Hyun Shim
Licochalcone C induces cell cycle G1 arrest and apoptosis in human esophageal squamous carcinoma cells by activation of the ROS/MAPK signaling pathway. Journal of chemotherapy (Florence, Italy) 32 (3) (2020)
Jian Li, Xinli Ma, Surajit Banerjee, Sankar Baruah, Nicholas J Schnicker, Eunmiri Roh, Weiya Ma, Kangdong Liu, Ann M Bode, Zigang Dong
Structural basis for multifunctional roles of human Ints3 C-terminal domain. The Journal of biological chemistry (2020)